Andrew Johnson

Andrew Johnson, Ph.D., is a technical leader with extensive experience in formulation, drug delivery, and process scale-up within the healthcare and pharmaceutical sectors. They have held positions at GSK and Haleon, where they led high-profile R&D projects, enhanced product quality, and successfully reduced production complexities. Awarded for their communication and problem-solving skills, Andrew has also collaborated with various stakeholders and external academic partners to drive innovation. Currently, they serve as the Head of Chemistry at Anaphite, continuing to contribute to advancements in their field. Andrew holds a Ph.D. in Physical Chemistry from the University of Hull.